Rapid commentary: Ethical implications for clinical trialists and patients associated with COVID-19 research.

Autor:	Delanerolle G; Department of Psychiatry, University of Oxford, Oxford OX3 7JX, United Kingdom., Rathod S; Research and Development Department, Southern Health NHS Foundation Trust, Southampton SO30 3JB, United Kingdom., Elliot K; Research and Development Department, Southern Health NHS Foundation Trust, Southampton SO30 3JB, United Kingdom., Ramakrishnan R; Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford OX3 7JX, United Kingdom., Thayanandan T; Department of Psychiatry, University of Oxford, Oxford OX3 7JX, United Kingdom., Sandle N; Department of Psychiatry, University of Oxford, Oxford OX3 7JX, United Kingdom., Haque N; Department of Psychiatry, University of Oxford, Oxford OX3 7JX, United Kingdom., Raymont V; Department of Psychiatry, University of Oxford, Oxford OX3 7JX, United Kingdom., Phiri P; Research and Development Department, Southern Health NHS Foundation Trust, Southampton SO30 3JB, United Kingdom.
Jazyk:	angličtina
Zdroj:	World journal of psychiatry [World J Psychiatry] 2021 Mar 19; Vol. 11 (3), pp. 58-62. Date of Electronic Publication: 2021 Mar 19 (Print Publication: 2021).
DOI:	10.5498/wjp.v11.i3.58
Abstrakt:	Pandemics disrupt clinical trials worldwide, with lasting effects on research. It can severely impact clinical trialists ability to conduct safe and ethically uncompromised trials. Hence, the mounting pressure results in ethically and morally distressing decisions faced by clinical trial professionals during pandemic situations. Whilst clinical trialists attempt to think about preparedness and responses during a pandemic, the need to have an ethical framework that has real-world applicability is imperative. Pandemics are a challenging time for all, however, the safety and access to support for clinical trialists and patients within clinical trials should be at the forefront for their organisations and the government. Competing Interests: Conflict-of-interest statement: Phiri P has received research grant from Novo Nordisk, and other, educational from Queen Mary University of London, other from John Wiley & Sons, other from Otsuka, outside the submitted work. Rathod S reports other from Janssen, Lundbeck and Otsuka outside the submitted work. All other authors report no conflict of interests for this article. The views expressed are those of the authors and not necessarily those of the NHS, the National Institute for Health Research, the Department of Health and Social Care or the Academic institutions. (©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu